Pharmaceutical Industry Use Case
Developing medicines to treat asthma can be time consuming and a complex process. This is especially true in pediatric medicine where children prefer oral alternatives to inhalers.
Formulators frequently start with baseline ingredient, montelukast sodium (CAS RN 151767-02-1) to make these drugs. To induce patient compliance, it is necessary to include other ingredients with montelukast sodium to make the product palatable. Learn how Formulus can help speed up the process.